Management of Children with Speech Disorders via Transcranial Magnetic Stimulation: Non-Randomized Controlled Study

Background. Speech development impairment is urgent and common problem in pediatric neurology. Transcranial magnetic stimulation (TMS) is one of the promising treatment variants for children with speech disorders. Objective. The aim of the study is to evaluate efficacy and safety of the developed approaches to TMS usage in the management of children with speech disorders. Methods. It was non-randomized controlled study. It included 46 children with speech disorders aged from 3 to 6.5 years. All children were divided into two groups comparable by gender and age: 26 children of the treatment group received TMS course, 20 children of the control group received treatment with hopantenic acid. All patients with speech disorders underwent psychological and pedagogical evaluation of speech and cognitive development, electroencephalography (EEG) before and after treatment. Moreover, comparative analysis of TMS and nootropic therapy efficacy was carried out. Specialized examination of speech and cognitive development was also performed via E.A. Strebeleva method for psychological and pedagogical diagnosis of children development. Furthermore, we carried out side reactions / adverse events registration according to patients and/or their parents complaints confirmed by physical examination, patient’s behavior observation, data from specially developed questionnaire for assessing child’s behavior and well-being (filled up by parents). Finally, we evaluated brain bioelectric activity recorded by EEG. Results. The study results have shown that it is possible to achieve significant positive dynamics in cognitive and speech development in preschool children with speech disorders in both groups (TMS course and medical treatment). But hereby, TMS treatment has demonstrated significantly higher positive dynamics in two out of the three evaluated parameters. There were no cases of adverse events in TMS group leading to early course discontinuation. Conclusion. TMS is non-invasive and safe method for treatment of children with speech disorders. This study has demonstrated the efficacy of the method in the field of personalized management of children with impaired speech and cognitive development.

1. Doruk Camsari D, Kirkovski M, Croarkin PE. Therapeutic applications of invasive neuromodulation in children and adolescents. Psychiatr Clin North Am. 2018;41(3):479–483. http://doi.org/10.1016/j.psc.2018.04.008

2. Finisguerra A, Borgatti R, Urgesi C. Non-invasive brain stimulation for the rehabilitation of children and adolescents with neurodevelopmental disorders: a systematic review. Front Psychol. 2019;10:135. http://doi.org/10.3389/fpsyg.2019.00135

3. Hameed MQ, Sameer C, Dhamne SC, et al. Transcranial magnetic and direct current stimulation in children. Curr Neurol Neurosci Rep. 2017;17(2):11. http://doi.org/10.1007/s11910-017-0719-0

4. Rajapakse T, Kirton A. Non-invasive brain stimulation in children: applications and future directions. Transl Neurosci. 2013;4(2):217–233. http://doi.org/10.2478/s13380-013-0116-3

5. Narayana S, Papanicolaou AC, McGregor A, et al. Clinical applications of transcranial magnetic stimulation in pediatric neurology. J Child Neurol. 2015;30(9):1111–1124. http://doi.org/10.1177/0883073814553274

6. Malone LA, Sun LR. Transcranial magnetic stimulation for the treatment of pediatric neurological disorders. Curr Treat Options Neurol. 2019;21(11):58. http://doi.org/10.1007/s11940-019-0600-3

7. Suponeva NA, Bakulin IS, Poydasheva AG, Piradov MA. Safety of transcranial magnetic stimulation: review of international guidelines and new findings. Neuromuscular Diseases. 2017;7(2):21–36. (In Russ). http://doi.org/10.17650/2222-8721-2017-7-2-21-36

8. Babajani-Feremi A, Narayana S, Rezaie R, et al. Language mapping using high gamma electrocorticography, fMRI, and TMS versus electrocortical stimulation. Clin Neurophysiol. 2016;127(3):1822–1836. https://doi.org/10.1016/j.clinph.2015.11.017

9. Carmi L, Tendler A, Bystritsky A. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry. 2019;176(11):931–938. https://doi.org/10.1176/appi.ajp.2019.18101180

10. Krishnan C, Santos L, Peterson MD, et al. Safety of noninvasive brain stimulation in children and adolescents. Brain Stimul. 2015;8(1):76–87. https://doi.org/10.1016/j.brs.2014.10.012

11. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–2039. http://doi.org/10.1016/j.clinph.2009.08.016

12. Allen CH, Kluger BM, Buard I. Safety of transcranial magnetic stimulation in children: a systematic review of the literature. Pediatr Neurol. 2017;68:3–17. http://doi.org/10.1016/j.pediatrneurol.2016.12.009

13. Garvey MA, Mall V. Transcranial magnetic stimulation in children. Clin Neurophysiol. 2008;119(5):973–984. http://doi.org/10.1016/j.clinph.2007.11.048

14. Frye RE, Rotenberg A, Ousley M, Pascual-Leone A. Transcranial magnetic stimulation in child neurology: current and future directions. J Child Neurol. 2008;23(1):79–96. http://doi.org/10.1177/0883073807307972

15. Nesterova JV, Karkashadze GA, Namazova-Baranova LS, et al. Treatment of Cognitive and Behavioral Disorders in Children Using Transcranial Magnetic Stimulation: Literature Review. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2021;18(6):498–506. (In Russ). http://doi.org/10.15690/pf.v18i6.2347

16. Karkashadze GA, Maslova OI, Namazova-Baranova LS. Current problems of diagnosis and treatment of mild cognitive impairments in children. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2011;8(5):37–41. (In Russ).

17. Lavrik SY, Shprakh VV, Alimova EB, et al. Use of transcranial magnetic stimulation in children with consequences of perinatal brain lesions. Acta Biomedica Scientifica. 2016;1(6):71–75. (In Russ). https://doi.org/10.12737/23746

18. Patent № 2675737 Russian Federation, IPC A61N 2/04 (2006.01). Delayed speech development treatment in children using the trans-cranial magnetic stimulation: № 2018117377: declare 10.05.2018: publ. 24.12.2018. Fetisova TV. 7 p. (In Russ).

19. Strebeleva EA. Methodological Recommendations to Psycho-pedagogical Examination of Children (2–3 year old): Early Diagnosing of Mental Development. Almanac Institute of special education. 2001;(4(3)). (In Russ). https://alldef.ru/ru/articles/almanah-4/metodicheskie-rekomendacii-k-psihologo-pedagogicheskomu.

20. Blagosklonova NK, Novikova LA. Detskaya klinicheskaya elektroentsefalografiya. Moscow: Meditsina; 1994. 206 p. (In Russ).

21. Baranov AA, Namazova-Baranova LS, Karkashadze GA. Novye neirobiologicheskie podkhody k profilaktike i lecheniyu perinatal’nykh porazhenii TsNS: osnovnye rezul’taty nauchnykh issledovanii. Moscow: Russian Academy of Sciences; 2017. 105 p. (In Russ).